Patent directory · USPTO A61K / A61P
Patents matching “Rigel Pharmaceuticals, Inc.”
373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12384775
Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors
granted -
US 12357623
Method for treating a disease or condition using a pyrazole compound or formulation thereof
granted -
US 12331036
Heterocyclic RIP1 kinase inhibitors
granted -
US 12297202
RIP1K inhibitors
granted -
US 12263180
Method for treatment of COVID-19-associated conditions
granted -
US 12227508
TGF-β inhibitors
granted -
US 12156880
Heterocyclic RIP1 kinase inhibitors
granted -
US 12116354
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 12043620
Benzazole compounds and methods for making and using the compounds
granted -
US 12043629
RIP1K inhibitors
granted -
US 11993594
IRAK inhibitors and method for making and using
granted -
US 11963958
RET inhibitor for use in treating cancer having a RET alteration
granted -
US 11939317
Amide compounds and method for making and using
granted -
US 11827628
Compositions and methods for inhibition of the JAK pathway
granted -
US 11672791
Tyrosine kinase inhibitors
granted -
US 11667643
RIP1K inhibitors
granted -
US 11667611
Compositions and methods for inhibition of the JAK pathway
granted -
US 11584758
RIP1K inhibitors
granted -
US 11578078
Heterocyclic RIP1 inhibitory compounds
granted -
US 11564930
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 11530194
Amide compounds and method for making and using
granted -
US 11524955
2,4-diamino-pyrimidine compounds and method for making and using the compounds
granted -
US 11492349
IRAK inhibitors and method for making and using
granted -
US 11479543
Heterocyclic RIP1 kinase inhibitors
granted